# National CounterACT Initiative

> **NCT03597438** · — · COMPLETED · sponsor: **Children's Hospital of Philadelphia** · enrollment: 236 (actual)

## Conditions studied

- Mitochondrial Alteration

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03597438
- **Lead sponsor:** Children's Hospital of Philadelphia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-07
- **Primary completion:** 2023-04-18
- **Final completion:** 2024-02-22
- **Target enrollment:** 236 (ACTUAL)
- **Last updated:** 2024-02-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03597438

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03597438, "National CounterACT Initiative". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03597438. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*